Neuroprotective effects of minocycline on double-stranded RNA-induced neurotoxicity in cultured cortical neurons by Yik, SY et al.
Title Neuroprotective effects of minocycline on double-stranded RNA-induced neurotoxicity in cultured cortical neurons
Author(s) Yik, SY; Yu, MS; Ho, YS; Lai, SW; Cheung, YT; So, KF; Chang,RCC
Citation Hong Kong Medical Journal, 2012, v. 18 n. 1, suppl 2, p. 42-44
Issued Date 2012
URL http://hdl.handle.net/10722/146384
Rights Creative Commons: Attribution 3.0 Hong Kong License
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES
42      Hong Kong Med J Vol 18 No 1 Supplement 2 February 2012
Neuroprotective effects of 
minocycline on double-stranded RNA-
induced neurotoxicity in cultured 
cortical neurons
SY Yik 易雪怡
MS Yu 余雯珊 
YS Ho 何宛姍 
CSW Lai 賴秀芸 
YT Cheung 張婉婷 
KF So 蘇國輝
RCC Chang 鄭傳忠
Key Messages
1. Minocycline, memantine, 
and glycoconjugate were 
assessed for their ability to 
protect cultured primary 
cortical neurons against 
double-stranded RNA-induced 
neurotoxicity.
2. Minocycline but not memantine 
or glycoconjugate protected 
cultured cells and warrants 
further investigation.
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Introduction
Japanese encephalitis virus (JEV) is an RNA virus spread by infected mosquitoes. 
Patients may develop symptoms such as fever, chills, tiredness, headache, nausea, 
vomiting, confusion, and agitation. The disease can lead to serious infection 
in the brain (encephalitis), and in about 30% of patients severe brain damage 
ensues. There is no specific treatment for the disease, and the role of medication 
is to relieve severe symptoms. 
 Few studies have reported on protection of neurons subsequent to viral 
infection. We hypothesise that neuroprotective drugs can be used to treat Japanese 
encephalitis patients and safeguard neurons. We tested some neuroprotective 
drugs from western and Chinese medicine (minocycline, memantine, and 
glycoconjugate) for treating Japanese encephalitis. The double-stranded RNA 
analogue, pIpC, is a commonly used analogue mimicking the consequence of 
virus infection. Cell cultures of neurons were used to investigate whether these 
three drugs could attenuate any direct toxic effects of pIpC toward neurons. The 
underlying mechanisms of the neuroprotective effects were also investigated.
 
 Minocycline is a semi-synthetic tetracycline derivative exhibiting biological 
effects of neuroprotection in different types of neurological disorders including 
Parkinson’s disease, amyotrophic lateral sclerosis, spinal cord injury, and 
cerebral ischaemia.1,2 Such neuroprotective effects are largely attributed to the 
inhibition of microglia and production of inflammatory factors. Minocycline can 
even attenuate the excitotoxicity of glutamate in the cerebrospinal fluid from 
amyotrophic lateral sclerosis patients. The pathology of Japanese encephalitis 
entails severe cerebral inflammation, which may be minimised by minocycline 
and so protect neurons. 
 Memantine is a non-competitive NMDA open channel blocker approved 
by the US Food and Drug Administration for neuroprotection in Alzheimer’s 
disease.3 Glutamate is usually released from injured or energy deficient neurons 
in many neurological disorders. It can further depolarise other healthy neurons 
and the potassium ions released from such depolarised neurons can enhance 
cerebral inflammation aggravating neuronal death.4 Memantine may serve 
as neuroprotective agent to minimise secondary brain damage exerted by 
glutamate. 
 Glycoconjugate is extracted from the anti-ageing Chinese medicine Lycium	
barbarum. It is neuroprotective against the toxicity exerted from β-amyloid 
protein, a toxin found in the Alzheimer’s disease, as well as retinal ganglion cells 
in an animal model of glaucoma.5 Its cytoprotective properties may extend to 
other neurodegenerative diseases and even Japanese encephalitis or its dsRNA-
elicited neurotoxicity. 
Methods
This study was conducted from 1 June 2006 to 31 May 2008. Protection of 
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neurons from the direct toxic effects of pIpC by the three 
drugs (minocycline, memantine, and glycoconjugate) was 
examined, using primary cultures of cortical neurons and 
human neuroblastoma SH-SY5Y cells. Primary cortical 
neurons were prepared from embryonic day 17 Sprague-
Dawley rats (Laboratory Animal Unit, The University of 
Hong Kong).6 In brief, cerebral cortices were mechanically 
dissociated in phosphate-buffered saline with glucose 
(18 mM). Cells were seeded onto six-well (0.8×106 cells/
well) or 12-well plates (1.0×105 cells/well) pre-coated with 
poly-L-lysine (25 μg/mL). The culture medium consisted 
of Neurobasal Medium supplemented with 2% B-27 
supplement, L-glutamine (2 mM), penicillin (50 U/mL), 
streptomycin (50 μg/mL), and 2-mercaptoethanol. Neurons 
were maintained at 37ºC in a humidified atmosphere of 5% 
CO
2
 and were cultured for 7 days prior to treatment.
 To evaluate whether minocycline exerted 
neuroprotective effects, neurons were pretreated with 
different dosages of potential drugs for 1 h prior to exposure 
of pIpC. Neurons were challenged by 20 μg/mL pIpC with 
FuGENE 6 reagent. After 48 h, neurons were harvested 
for assay. General toxicity was determined by measuring 
lactate dehydrogenase (LDH) activity released into culture 
medium. Apoptosis was assessed by determining caspase-3 
activity. TUNEL and DAPI nuclear staining were used to 
count the number of apoptotic bodies.
 All results obtained were expressed as mean±standard 
error from at least three independent experiments. 
Significant difference between groups was determined by 
one-way ANOVA, followed by Student-Newman-Keuls as 
a post hoc test. 
Fig. Effects of minocycline, memantine, and glycoconjugate on pIpC-induced neurotoxicity
Cultured cortical neurons were treated with (a) minocycline, (b) memantine, or (c) glycoconjugate at different dosages 1 h prior to the 
exposure of 20 μg/mL pIpC. Culture medium was taken for lactate dehydrogenase (LDH) assay and cells were harvested for caspase-3 
assay 24 h after treatment
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Results and discussion
pIpC exhibits direct neurotoxicity. Increased levels of 
dsRNA produced from JEV can be toxic to cortical neurons. 
Dose-dependent and time-dependent experiments were 
performed using primary cultures of cortical neurons and 
SH-SY5Y cells as two different models.
 Exposure of neurons to 20 μg/mL pIpC resulted in 
1.23±0.02-fold increase in the release of LDH when 
compared to the vehicle control. At higher dosage, the 
release of LDH decreased to 1.15±0.03-fold. Thus, 20 μg/
mL pIpC was chosen for the subsequent experiments. As 
pIpC could trigger its neurotoxicity via activating caspase-3, 
a colorimetric caspase-3-like activity assay was carried out 
for different dosages of pIpC. Exposure of neurons to 20 μg/
mL pIpC significantly increased the activity of caspase-3 to 
1.33±0.06-fold.
 Apart from biochemical assays, neurites were damaged 
by pIpC, as shown by their morphology. Under a phase 
contrast microscope, the cell bodies of cultured neurons in 
the control group appeared round and dark with a network 
of process. After exposure to pIpC, cultured neurons were 
damaged and showed fragmented neurites.
 Exposure of neurons to 20 μg/mL pIpC for 48 h 
resulted in 1.2±0.03-fold increase in the release of LDH 
when compared to the vehicle control. There was a slight 
decrease of LDH release at 72 h. The colorimetric caspase-
3-like activity assay was also carried out after different 
durations of exposure to pIpC. Exposure of neurons to 20 
μg/mL pIpC for 48 h significantly increased the activity of 
caspase-3 to 1.43±0.03-fold. Similar to the results of the 
LDH release assay, caspase-3-like activity decreased at 72 
h. As the maximum increase of LDH release and caspase-3 
was at 48 h, this duration was chosen for the subsequent 
experiments.
 Exposure of human dopaminergic SH-SY5Y cell 
neurons to 20 μg/mL pIpC resulted in 1.50±0.09-fold 
increase of LDH release when compared to that of 
the vehicle control. Exposure of neurons to 20 μg/mL 
pIpC significantly increased the activity of caspase-3 to 
1.29±0.03-fold. These results provided further proof of 
the toxicity of pIpC, using SH-SY5Y cells as second cell 
culture model.
 pIpC induced neuronal apoptosis can be confirmed 
by recognised methods. Treatment with pIpC for 48 h 
increased the number of apoptotic bodies (typical nuclear 
condensation and fragmentation) as indicated by the 
increased number of TUNEL-positive neurons. TUNEL 
assay relied on the detection of fragmented DNA strands. 
In control cultures treated with vehicle, only few TUNEL-
positive cells were observed.
 Minocycline exhibited the best neuroprotective 
effect on neurons based on the LDH assay; 10 or 20 μM 
exerted similar neuroprotection on caspase-3 activity (Fig 
a). We could not further increase the concentrations of 
minocycline as this would exceed the normal dosage for 
treatment and exert side-effect in patients. Memantine 
significantly reduced the toxicity of pIpC (both LDH release 
and caspase-3 activity), but its neuroprotective effect was 
marginal. In contrast to memantine, minocycline elicited 
significant neuroprotective effects on cortical neurons 
against direct pIpC toxicity (Fig b). Glycoconjugates from 
L	 barbarum elicited cytoprotective effects; L	 barbarum 
attenuated caspase-3 activity triggered by pIpC (Fig c). 
Nonetheless, only the highest dosage of L	barbarum could 
inhibit LDH release triggered by pIpC.
 Of the three different compounds, minocycline 
exhibited significant neuroprotective effects against direct 
pIpC neurotoxicity and warrants further investigation.
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